Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Feb-2026 | 319.9 | 324.9 | 306.65 | 318.55 | 3,560 | 3,99,13,899.65 | 48,512 |
02-Feb-2026 | 314.95 | 319.9 | 307.8 | 315.1 | 4,848 | 4,63,17,259.2 | 46,077 |
03-Feb-2026 | 323 | 329.9 | 312.6 | 314.3 | 4,630 | 5,41,84,810.25 | 73,358 |
04-Feb-2026 | 316.2 | 324.65 | 311.6 | 322.25 | 3,404 | 4,11,50,098.15 | 61,772 |
05-Feb-2026 | 320.65 | 327 | 318.9 | 320.45 | 3,094 | 3,07,27,394.35 | 43,334 |
06-Feb-2026 | 320.75 | 328.4 | 315 | 318 | 4,472 | 5,50,43,145.9 | 62,802 |
09-Feb-2026 | 317.15 | 339 | 310 | 320.2 | 12,529 | 18,60,35,829.1 | 2,44,468 |
10-Feb-2026 | 322 | 323.85 | 317.1 | 318.5 | 2,488 | 3,48,31,709.35 | 55,475 |
11-Feb-2026 | 318.8 | 324.35 | 317.2 | 318.95 | 1,911 | 3,17,96,755.5 | 47,719 |
12-Feb-2026 | 320.2 | 353 | 317.1 | 350.8 | 30,113 | 75,22,60,381.9 | 4,28,581 |
13-Feb-2026 | 342 | 349.2 | 333.15 | 337.15 | 7,391 | 8,05,98,754.95 | 1,01,547 |
16-Feb-2026 | 335 | 344.9 | 331.55 | 340.2 | 6,135 | 6,52,89,238.75 | 71,746 |
17-Feb-2026 | 342.8 | 371.8 | 337 | 367.5 | 35,019 | 69,60,17,135.55 | 3,96,978 |
18-Feb-2026 | 367.5 | 375 | 358.95 | 369.7 | 15,004 | 20,89,76,840.45 | 1,62,427 |
19-Feb-2026 | 360.9 | 369 | 355.8 | 358 | 4,934 | 6,19,37,996 | 80,245 |
20-Feb-2026 | 360 | 387.5 | 354.7 | 372.45 | 26,331 | 48,83,34,597.6 | 2,17,122 |
23-Feb-2026 | 383.4 | 383.4 | 368.8 | 375.3 | 8,446 | 11,32,43,141.45 | 88,481 |
24-Feb-2026 | 375.2 | 386 | 368.05 | 380.8 | 8,336 | 10,28,60,956.7 | 79,188 |
25-Feb-2026 | 381.9 | 385.85 | 376.55 | 380.9 | 5,127 | 8,14,15,784.35 | 62,077 |
26-Feb-2026 | 378.5 | 394.25 | 378.5 | 389.4 | 12,188 | 21,16,89,728.85 | 1,56,377 |
27-Feb-2026 | 390 | 403 | 380.5 | 385.2 | 20,464 | 26,96,63,915.8 | 2,40,923 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
